Evidence map›Paper›PMID 28696432›Full record

ArticleMolecular psychiatry2018

Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood.

N Dedic, M L Pöhlmann, J S Richter, D Mehta, D Czamara, M W Metzger, J Dine, B T Bedenk, J Hartmann, K V Wagner and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 4 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 4 syntheses or guidelines pooled it, 175 citations in OpenAlex.

  1. Pooled it
  2. Vitamin D and schizophrenia: 20 years on.Molecular psychiatry · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Schizophrenia: from mechanism to therapy.Science China. Life sciences · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Probing neuropsychiatric disorders through in vivo CRISPR screening.Current opinion in genetics & development · 2026
    Review
  13. Article
  14. Epigenetic Mechanisms of Suicidal Behavior Formation: A Review.Medical journal of the Islamic Republic of Iran · 2026
    Review
  15. Deletion ofFrontiers in cellular neuroscience · 2026
    Article
  16. Astrocytic abnormalities in brain-specificChannels (Austin, Tex.) · 2025
    Article
  17. Deletion ofbioRxiv : the preprint server for biology · 2025
    Article
  18. Article
  19. Structure of a polymorphic repeat at theProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. The Impact of Overexpression of the Mouse Ortholog ofBiological psychiatry global open science · 2025
    Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 4 countries.

N DedicMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
M L PöhlmannMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
J S RichterMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
D MehtaQueensland Brain Institute, University of Queensland, St. Lucia, QLD, Australia.
D CzamaraQueensland Brain Institute, University of Queensland, St. Lucia, QLD, Australia.
M W MetzgerMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
J DineMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
B T BedenkMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
J HartmannMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
K V WagnerMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
A JurikInstitute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany.
L M AlmliDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
A LoriDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
S MoosmangInstitute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany.
F HofmannInstitute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany.
C T WotjakMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
G RammesClinic of Anaesthesiology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
M EderMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
A ChenMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
K J ResslerDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
W WurstInstitute of Developmental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
M V SchmidtMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
E B BinderDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
J M DeussingMolecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
Max Planck Institute of Psychiatry · DETechnical University of Munich · DEEmory University · USHelmholtz Zentrum München · DEMcLean Hospital · USUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-nucleotide polymorphisms (SNPs) in CACNA1C, the α1C subunit of the voltage-gated L-type calcium channel Ca

Indexed as

AdultAnimalsBipolar DisorderBlack or African AmericanCalcium ChannelsCalcium Channels, L-TypeDisease Models, AnimalFemaleGenetic Predisposition to DiseaseGenetic VariationHumansMajor Depressive DisorderMaleMental DisordersMiceMice, TransgenicCACNA1C protein, humanCACNA1C protein, mouseCalcium ChannelsCalcium Channels, L-Type

Identifiers

PMID28696432
PMCPMC5822460
OpenAlexW2734391724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.